Renal anemia is caused by a lack of erythropoietin, a protein made in the kidneys that helps make red blood cells. It is a sign of kidney failure and affects cognitive abilities, immune system response, and cardio functions. Early diagnosis is essential, and doctors have developed a plan to identify and manage the disease, known as the renal anemia management period (RAMP). Treatment options include epoetin and artificial production of red blood cells.
Renal anemia is a disease in which the patient has an unusually low number of red blood cells. Renal is a term for the kidneys, so anemia is often associated with kidney disease. This type of anemia is caused by a lack of erythropoietin, a protein made in the kidneys that helps make red blood cells.
Another cause of anemia is hemolysis, the breakdown of red blood cells in abnormal places within the body, such as blood vessels. Additionally, iron and vitamin B12 deficiencies can lead to kidney disease. Renal anemia is a sign of kidney failure. Kidney dialysis anemia involves a blood filtering treatment to remove excess waste.
Anemia of chronic kidney disease is common because a low red blood cell count is one of the first signs of kidney disease. Renal anemia develops early in patients with chronic kidney disease (CKD), and the anemia worsens over time as CKD progresses. CKD anemia affects cognitive abilities, immune system response, and cardio functions, as well as a person’s ability to exercise or strain bodily systems. In regards to CKD, anemia can also be caused by iron deficiency, acute or chronic inflammatory conditions, aluminum toxicity, and shorter red blood cell survival times. The progression of chronic kidney disease is characterized by five stages, the last of which is dialysis, and renal anemia typically presents between stages three and five.
This type of anemia affects almost every organ in the body, either directly or indirectly. A combination of high blood pressure and anemia can cause left ventricular hypertrophy (LVH), a complication that results from changes in left ventricular wall stress. Severe cases of anemia can lead to hospitalization and even death.
Since it is a gradually worsening disease, early diagnosis is essential. Doctors have developed a plan to identify and manage the disease, known as the renal anemia management period (RAMP). This plan places great emphasis on the debilitating effects of anemia that get worse the longer it goes untreated. It tries to prevent the formation of other diseases and complications, such as LVH, by curbing the effects of anemia as quickly as possible.
When an anemia patient is identified as having stage 3 chronic kidney disease, doctors usually choose to monitor their symptoms so they can intervene quickly if needed. This includes measuring the patient’s weight, diet, energy and protein intake, serum cholesterol level, calcium, phosphorus, and general health and well-being. Epoetin is a type of treatment for renal anemia that can reduce the risk of LVH. Also, the artificial production of more red blood cells can cure anemia, but complications have been demonstrated with this, as genetic engineering is still in its pioneering stage.
Protect your devices with Threat Protection by NordVPN
